Hypoxia-responsive miR-124 and miR-144 reduce hypoxia-induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hypoxia-responsive miR-124 and miR-144 reduce hypoxia-induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1
Authors
Keywords
-
Journal
Cancer Medicine
Volume 5, Issue 6, Pages 1174-1182
Publisher
Wiley
Online
2016-03-18
DOI
10.1002/cam4.664
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoxia-induced autophagy promotes human prostate stromal cells survival and ER-stress
- (2015) Nan Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells
- (2015) Wei Zhang et al. Cancer Cell International
- miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
- (2015) X.-B. Shi et al. CANCER RESEARCH
- Autophagic degradation of the androgen receptor mediated by increased phosphorylation of p62 suppresses apoptosis in hypoxia
- (2015) Takakazu Mitani et al. CELLULAR SIGNALLING
- Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer
- (2015) Yan Li et al. Scientific Reports
- Biphasic regulation of autophagy by miR-96 in prostate cancer cells under hypoxia
- (2015) Yi Ma et al. Oncotarget
- MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin
- (2015) Zhiyu Wang et al. Oncotarget
- Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy
- (2014) Lei Chang et al. CANCER AND METASTASIS REVIEWS
- PIM1 Kinase as a Target in Prostate Cancer: Roles in Tumorigenesis, Castration Resistance, and Docetaxel Resistance
- (2014) Sheldon Holder et al. CURRENT CANCER DRUG TARGETS
- Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance
- (2014) Wei Yang et al. EXPERIMENTAL CELL RESEARCH
- PIM kinases: an overview in tumors and recent advances in pancreatic cancer
- (2014) Jianwei Xu et al. Future Oncology
- MiR-200c inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1
- (2014) Quanquan Sun et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-21 is a novel promising target in cancer radiation therapy
- (2014) Jia Liu et al. TUMOR BIOLOGY
- Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER
- (2014) Twan van den Beucken et al. Nature Communications
- Hypoxia-Induced Autophagy Confers Resistance of Breast Cancer Cells to Ionizing Radiation
- (2013) Wen-Shan He et al. ONCOLOGY RESEARCH
- Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells
- (2012) X-B Shi et al. ONCOGENE
- Exposure to hypoxia following irradiation increases radioresistance in prostate cancer cells
- (2012) Derek Hennessey et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- AMPK-mediated autophagy is a survival mechanism in androgen-dependent prostate cancer cells subjected to androgen deprivation and hypoxia
- (2011) Rishi Raj Chhipa et al. CELLULAR SIGNALLING
- Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma
- (2010) Carolin Reiser-Erkan et al. CANCER BIOLOGY & THERAPY
- Hypoxia-Mediated Up-Regulation of Pim-1 Contributes to Solid Tumor Formation
- (2009) Jian Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- The PIM1 Kinase Is a Critical Component of a Survival Pathway Activated by Docetaxel and Promotes Survival of Docetaxel-treated Prostate Cancer Cells
- (2008) Marina Zemskova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now